rel-(1R,3R)-3-Amino-2,2-dimethylcyclobutane-1-carboxylic acid hydrochloride

Catalog No. :
ACHXYB897
CAS No. :
1392803-36-9
Molecular Formula :
C7H14ClNO2
Molecular Weight :
179.65

IUPAC Name:(1R,3R)-3-amino-2,2-dimethylcyclobutane-1-carboxylic acid hydrochloride

rel-(1R,3R)-3-Amino-2,2-dimethylcyclobutane-1-carboxylic acid hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$405.00Login to see priceInquiryInquiry
250mg98%$491.00Login to see priceInquiryInquiry
1g98%$1227.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namerel-(1R,3R)-3-Amino-2,2-dimethylcyclobutane-1-carboxylic acid hydrochloride
IUPAC Name(1R,3R)-3-amino-2,2-dimethylcyclobutane-1-carboxylic acid hydrochloride
MDL No.MFCD23106168
Molecular FormulaC7H14ClNO2
Molecular Weight179.65
SMILESO=C([C@H]1C(C)(C)[C@H](N)C1)O.[H]Cl
InChI KeyHMDTZGADNNOTKS-UYXJWNHNSA-N
Synonymtrans-3-Amino-2,2-dimethylcyclobutane-carboxylic acid hydrochloride;TRANS-3-AMINO-2,2-DIMETHYLCYCLOBUTANECARBOXYLIC ACID HCL;(1S,3S)-3-amino-2,2-dimethylcyclobutane-1-carboxylic acid;(1s,3s)-3-amino-2,2-dimethylcyclobutane-1-carboxylic acid hydrochloride
CAS No.1392803-36-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACHXYB897 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOWAC853 route compound structure diagram
    ACOWAC8531392803-26-7 In Stock
  2. Then
  3. ACHXYB897 route product structure diagram
    ACHXYB8971392803-36-9
Inquiry

2. ACHXYB897 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHXYB897 route product structure diagram
    ACHXYB8971392803-36-9
Inquiry

Comments (0)